ID

24188

Beskrivning

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Nyckelord

Versioner (2)
  1. 2017-07-27 2017-07-27 -
  2. 2017-08-08 2017-08-08 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

27 juli 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Engelsk

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 Formulär  
ELIGIBILITY QUESTION
Beskrivning

ELIGIBILITY QUESTION

Alias
UMLS CUI-1
C0013893
Did the subject meet all the randomisation criteria?
Beskrivning

randomisation criteria

Datatyp

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0243161
INCLUSION CRITERIA
Beskrivning

INCLUSION CRITERIA

Alias
UMLS CUI-1
C1512693
Achieves a BDI focal score of ≤ 7 units at Visit 2
Beskrivning

baseline dysnpnoea index

Datatyp

boolean

Alias
UMLS CUI [1]
C1511069
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
Beskrivning

VAS referring to COPD symptoms

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3536884
UMLS CUI [1,2]
C1737716
Is able to complete a Daily Record Card.
Beskrivning

ability of daily documentation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0920316
UMLS CUI [1,2]
C0332173
UMLS CUI [1,3]
C0085732
Is able to demonstrate correct use of DISKUS/ACCUHALER.
Beskrivning

ability to show the correct inhaler technique

Datatyp

boolean

Alias
UMLS CUI [1]
C0419833
EXCLUSION CRITERIA
Beskrivning

EXCLUSION CRITERIA

Alias
UMLS CUI-1
C0680251
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
Beskrivning

incomplete documentation of the daily record card

Datatyp

boolean

Alias
UMLS CUI [1]
C3845717
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
Beskrivning

abnormal clinical haematology and chemistry or cortisol level

Datatyp

boolean

Alias
UMLS CUI [1]
C1332129
UMLS CUI [2]
C0428396
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
Beskrivning

COPD exacerbation

Datatyp

boolean

Alias
UMLS CUI [1]
C0740304
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
Beskrivning

change in COPD medication or medication other than the permitted

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0024117
UMLS CUI [1,2]
C0580105
UMLS CUI [2]
C1115771
Tillbaka till toppen

Similar models

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
ELIGIBILITY QUESTION
C0013893 (UMLS CUI-1)
Item
Did the subject meet all the randomisation criteria?
text
C0034656 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
randomisation criteria
Code List
Did the subject meet all the randomisation criteria?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
INCLUSION CRITERIA
C1512693 (UMLS CUI-1)
baseline dysnpnoea index
Item
Achieves a BDI focal score of ≤ 7 units at Visit 2
boolean
C1511069 (UMLS CUI [1])
visual analog scale of COPD symptoms
Item
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
boolean
C3536884 (UMLS CUI [1,1])
C1737716 (UMLS CUI [1,2])
ability of daily documentation
Item
Is able to complete a Daily Record Card.
boolean
C0920316 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
ability to show the correct inhaler technique
Item
Is able to demonstrate correct use of DISKUS/ACCUHALER.
boolean
C0419833 (UMLS CUI [1])
Item Group
EXCLUSION CRITERIA
C0680251 (UMLS CUI-1)
incomplete documentation of the daily record card
Item
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
boolean
C3845717 (UMLS CUI [1])
abnormal clinical haematology and chemistry or cortisol level
Item
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
boolean
C1332129 (UMLS CUI [1])
C0428396 (UMLS CUI [2])
COPD exacerbation
Item
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
boolean
C0740304 (UMLS CUI [1])
change in COPD medication or medication other than the permitted
Item
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
boolean
C0024117 (UMLS CUI [1,1])
C0580105 (UMLS CUI [1,2])
C1115771 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial